News

April 10th, 2020

inSoma Accepted to Y-Combinator

We are thrilled to announce our acceptance into the summer 2020 batch of Y-Combinator. YC is a California-based startup-accelerator responsible for >$300B in combined valuation, including companies such as Airbnb, Dropbox, and Ginko Bioworks.

Read whole article
September 10th, 2019

Duke-Coulter Translational Partnership Funding

We are pleased to announce that inSoma Researchers working at Duke University will receive funding support from the Coulter Foundation to advance the commercialization of our Fractomer technology. Since 2006, Duke’s translational partnership with the Wallace H. Coulter Foundation has supported collaborative research projects that address unmet clinical needs and lead to improvements in health care and to commercial products.

Read whole article
September 8th, 2019

inSoma Receives NIH Funding Support

inSoma Bio is pleased to announce our first STTR award through the National Cancer Institute. This grant, lead by Drs. Stefan Roberts and Scott Hollenbeck will evaluate the ability of our technology to improve patient outcomes in reconstructive plastic surgery.